- About About
-
Medical
Medical
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
-
-
Attention Pennsylvanians: Take Action Today on SB 3!
There will finally be a vote on Pennsylvania SB 3 on the floor of the PA House of Representatives this Tuesday, March 15. While ASA is not completely happy with many of the limitations that have been included added to the bill in its current form, we are encouraging patient advocates to urge their state representatives to vote yes on SB 3.
As you are probably aware, it has been a very difficult process to get a piece of medical cannabis legislation this far in the Pennsylvania General Assembly. Despite the shortcomings in the bill, passage of SB 3 will enable the regulatory process to start as soon as possible, which is the one of the crucial components in making sure cultivators and dispensaries get licensed. Without these entities, there will be no medical cannabis access in Pennsylvania. It has taken anywhere between 18 and 36 months from passage a new state medical cannabis bill until dispensaries open up, therefore, get the process started is paramount. Other components of the program can be fixed with subsequent legislation while the regulatory and licensing process plays out.
To be sure, there are many improvements that need to be made to SB 3. For example, the qualifying conditions language should not imposed barriers to chronic pain patients that would deny them access if other treatment options are available. Better yet, physicians should be able to recommend for any condition for which the benefit outweighs the risk. Other notable problems with the bill are the restrictions on raw flowers and a possible cap on THC percentage.
In addition to SB 3, Pennsylvania patients need action at the federal level to protect their program once it is passed into law. Please join ASA in Washington, D.C. March 18-22 for the National Medical Cannabis Unity Conference and Lobby Day, as patients from across the country to lobby Congress in support of the CARERS Act.
Take Action Today by e-mailing your state representative, urging them to pass SB 3 without adding amendments that would limit patient access.
Share
Focus on Your State!
